Quince Therapeutics Inc - US Equity Option
Quince Therapeutics Inc - US Equity Option is a security (CUSIP 22053A206) tracked across SEC portfolio filings. 4 institutional managers reported $29K on Form 13F as of 2026-03-31; 1 registered fund positions totaling $13 via N-PORT as of 2026-05-29.
Summary
- Issuer: Quince Therapeutics Inc - US
- Class: Equity Option
- CUSIP: 22053A206
- Asset category: EC
- 13F holders: 4
- 13F value: $29K
- 13F period: 2026-03-31
- N-PORT fund positions: 1
- N-PORT value: $13
- N-PORT report: 2026-05-29
Top institutional holders (Form 13F)
Top fund holders (N-PORT)
| Fund | Registrant | Value | % of fund |
|---|
| Guggenheim Active Allocation Fund | Guggenheim Active Allocation Fund | $13 | 0.00% |
More